Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow‐up
Gespeichert in:
| Veröffentlicht in: | British journal of haematology 2008-10, Vol.143 (2), p.296-298 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 298 |
|---|---|
| container_issue | 2 |
| container_start_page | 296 |
| container_title | British journal of haematology |
| container_volume | 143 |
| creator | Cervetti, Giulia Galimberti, Sara Andreazzoli, Francesca Fazzi, Rita Cecconi, Nadia Caracciolo, Francesco Petrini, Mario |
| description | |
| doi_str_mv | 10.1111/j.1365-2141.2008.07333.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69752497</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69752497</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4173-ec0e724501f38f2c499a0d6ac0e7ade8a4801450083461e6cceb2ab0cfff482d3</originalsourceid><addsrcrecordid>eNqNkE1OwzAQhS0EoqVwBeQVu4Rx7CYuEguogIIqISFYW24yES75KXaipjuOwBk5CQ6tYIs3Hvm9N575CKEMQubP-TJkPB4HERMsjABkCAnnPOz2yPBX2CdDAEgCBkIOyJFzSwDGYcwOyYDJhAGXYkj0k2nazpR6QbWjjUXdlFg1NK8tLU3lhYJadCZrfZEZh9ohNRV91cZuaIpFQQts3zSWRl9Q7BqsMsx8vCjq9dfHZ7s6Jge5Lhye7O4Rebm9eZ7Ogvnj3f30ah6kgiU8wBQwicQYWM5lHqViMtGQxbp_1hlKLSQwL4PkImYYpykuIr2ANM9zIaOMj8jZtu_K1u8tukaVxvUD6grr1ql4kowjMUm8UW6Nqa2ds5irlfV72o1ioHq8aql6iqqnqHq86gev6nz0dPdHuygx-wvueHrD5dawNgVu_t1YXT_M-op_A8E5iww</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69752497</pqid></control><display><type>article</type><title>Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow‐up</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><creator>Cervetti, Giulia ; Galimberti, Sara ; Andreazzoli, Francesca ; Fazzi, Rita ; Cecconi, Nadia ; Caracciolo, Francesco ; Petrini, Mario</creator><creatorcontrib>Cervetti, Giulia ; Galimberti, Sara ; Andreazzoli, Francesca ; Fazzi, Rita ; Cecconi, Nadia ; Caracciolo, Francesco ; Petrini, Mario</creatorcontrib><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/j.1365-2141.2008.07333.x</identifier><identifier>PMID: 18710384</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Antibodies, Monoclonal - therapeutic use ; Antibodies, Monoclonal, Murine-Derived ; cladribrine ; Female ; Follow-Up Studies ; HCL ; Humans ; Immunologic Factors - therapeutic use ; Leukemia, Hairy Cell - drug therapy ; Male ; Middle Aged ; minimal residual disease ; Neoplasm, Residual - drug therapy ; Rituximab ; Treatment Outcome</subject><ispartof>British journal of haematology, 2008-10, Vol.143 (2), p.296-298</ispartof><rights>2008 The Authors. Journal Compilation © 2008 Blackwell Publishing Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4173-ec0e724501f38f2c499a0d6ac0e7ade8a4801450083461e6cceb2ab0cfff482d3</citedby><cites>FETCH-LOGICAL-c4173-ec0e724501f38f2c499a0d6ac0e7ade8a4801450083461e6cceb2ab0cfff482d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2141.2008.07333.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2141.2008.07333.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,1435,27933,27934,45583,45584,46418,46842</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18710384$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cervetti, Giulia</creatorcontrib><creatorcontrib>Galimberti, Sara</creatorcontrib><creatorcontrib>Andreazzoli, Francesca</creatorcontrib><creatorcontrib>Fazzi, Rita</creatorcontrib><creatorcontrib>Cecconi, Nadia</creatorcontrib><creatorcontrib>Caracciolo, Francesco</creatorcontrib><creatorcontrib>Petrini, Mario</creatorcontrib><title>Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow‐up</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><subject>Adult</subject><subject>Aged</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antibodies, Monoclonal, Murine-Derived</subject><subject>cladribrine</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>HCL</subject><subject>Humans</subject><subject>Immunologic Factors - therapeutic use</subject><subject>Leukemia, Hairy Cell - drug therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>minimal residual disease</subject><subject>Neoplasm, Residual - drug therapy</subject><subject>Rituximab</subject><subject>Treatment Outcome</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE1OwzAQhS0EoqVwBeQVu4Rx7CYuEguogIIqISFYW24yES75KXaipjuOwBk5CQ6tYIs3Hvm9N575CKEMQubP-TJkPB4HERMsjABkCAnnPOz2yPBX2CdDAEgCBkIOyJFzSwDGYcwOyYDJhAGXYkj0k2nazpR6QbWjjUXdlFg1NK8tLU3lhYJadCZrfZEZh9ohNRV91cZuaIpFQQts3zSWRl9Q7BqsMsx8vCjq9dfHZ7s6Jge5Lhye7O4Rebm9eZ7Ogvnj3f30ah6kgiU8wBQwicQYWM5lHqViMtGQxbp_1hlKLSQwL4PkImYYpykuIr2ANM9zIaOMj8jZtu_K1u8tukaVxvUD6grr1ql4kowjMUm8UW6Nqa2ds5irlfV72o1ioHq8aql6iqqnqHq86gev6nz0dPdHuygx-wvueHrD5dawNgVu_t1YXT_M-op_A8E5iww</recordid><startdate>200810</startdate><enddate>200810</enddate><creator>Cervetti, Giulia</creator><creator>Galimberti, Sara</creator><creator>Andreazzoli, Francesca</creator><creator>Fazzi, Rita</creator><creator>Cecconi, Nadia</creator><creator>Caracciolo, Francesco</creator><creator>Petrini, Mario</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200810</creationdate><title>Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow‐up</title><author>Cervetti, Giulia ; Galimberti, Sara ; Andreazzoli, Francesca ; Fazzi, Rita ; Cecconi, Nadia ; Caracciolo, Francesco ; Petrini, Mario</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4173-ec0e724501f38f2c499a0d6ac0e7ade8a4801450083461e6cceb2ab0cfff482d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antibodies, Monoclonal, Murine-Derived</topic><topic>cladribrine</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>HCL</topic><topic>Humans</topic><topic>Immunologic Factors - therapeutic use</topic><topic>Leukemia, Hairy Cell - drug therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>minimal residual disease</topic><topic>Neoplasm, Residual - drug therapy</topic><topic>Rituximab</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cervetti, Giulia</creatorcontrib><creatorcontrib>Galimberti, Sara</creatorcontrib><creatorcontrib>Andreazzoli, Francesca</creatorcontrib><creatorcontrib>Fazzi, Rita</creatorcontrib><creatorcontrib>Cecconi, Nadia</creatorcontrib><creatorcontrib>Caracciolo, Francesco</creatorcontrib><creatorcontrib>Petrini, Mario</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cervetti, Giulia</au><au>Galimberti, Sara</au><au>Andreazzoli, Francesca</au><au>Fazzi, Rita</au><au>Cecconi, Nadia</au><au>Caracciolo, Francesco</au><au>Petrini, Mario</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow‐up</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2008-10</date><risdate>2008</risdate><volume>143</volume><issue>2</issue><spage>296</spage><epage>298</epage><pages>296-298</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>18710384</pmid><doi>10.1111/j.1365-2141.2008.07333.x</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-1048 |
| ispartof | British journal of haematology, 2008-10, Vol.143 (2), p.296-298 |
| issn | 0007-1048 1365-2141 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69752497 |
| source | MEDLINE; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection) |
| subjects | Adult Aged Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Murine-Derived cladribrine Female Follow-Up Studies HCL Humans Immunologic Factors - therapeutic use Leukemia, Hairy Cell - drug therapy Male Middle Aged minimal residual disease Neoplasm, Residual - drug therapy Rituximab Treatment Outcome |
| title | Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow‐up |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T09%3A02%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rituximab%20as%20treatment%20for%20minimal%20residual%20disease%20in%20hairy%20cell%20leukaemia:%20extended%20follow%E2%80%90up&rft.jtitle=British%20journal%20of%20haematology&rft.au=Cervetti,%20Giulia&rft.date=2008-10&rft.volume=143&rft.issue=2&rft.spage=296&rft.epage=298&rft.pages=296-298&rft.issn=0007-1048&rft.eissn=1365-2141&rft_id=info:doi/10.1111/j.1365-2141.2008.07333.x&rft_dat=%3Cproquest_cross%3E69752497%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69752497&rft_id=info:pmid/18710384&rfr_iscdi=true |